Trials / Completed
CompletedNCT01635855
Belotero Post Approval Study
Belotero® Post Approval Study for the Treatment of Nasolabial Folds
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
A prospective, open-label 1-month post-approval study to evaluate the short term safety of Belotero® Balance in the re-treatment of nasolabial folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Belotero® | Hyaluronic acid dermal filler |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-07-10
- Last updated
- 2014-07-04
- Results posted
- 2014-07-04
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01635855. Inclusion in this directory is not an endorsement.